Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/18381791

Download in:

View as

General Info

PMID
18381791